Clinical Trials

Scientists in the CAPMM have invented technology to make basic discoveries about disease mechanisms, to profile molecules relevant to individualized patient therapy, discover new chemoprevention strategies, and test these discoveries and hypothesis in clinical trials. The Center for Applied Proteomics and Molecular Medicine is working in collaboration with Inova Fairfax Hospital and the Side-Out Foundation to conduct clinical trials for breast cancer prevention and personalized breast cancer treatment. More clinical trials are being planned for other cancers.

The team also developed a nanoparticle technology, licensed to Ceres Nanosciences, which is being evaluated in a clinical trial at Inova Fairfax Hospital for early detection of Lyme disease.